MIF (Protein|Antibody|cDNA Clone|ELISA Kit)

All MIF reagents are produced in house and quality controlled, including 4 MIF Antibody, 24 MIF Gene, 1 MIF IPKit, 2 MIF Lysate, 3 MIF Protein, 2 MIF qPCR. All MIF reagents are ready to use.

Recombinant MIF proteins are expressed by E. coli, HEK293 Cells with fusion tags as Native, C-His.

MIFantibodies are validated with different applications, which are ELISA, WB, IP.

MIFcDNA clones are full length sequence confirmed and expression validated. There are 13 kinds of tags for each MIF of different species, especially GFP tag, OFP tag, FLAG tag and so on. There are three kinds of vectors for choice, cloning vector, expression vector and lentivrial expression vector.

MIF Protein (3)


MIF Protein, Mouse, Recombinant


Expression host: E. coli

Mouse MIF Protein 11359

MIF Protein, Human, Recombinant (His Tag)


Expression host: HEK293 Cells

Human MIF Protein 8589

MIF Protein, Mouse, Recombinant (His Tag)


Expression host: HEK293 Cells

Mouse MIF Protein 11358

MIF Antibody (4)

Application Clonality

Anti-MIF Antibody


Application: ELISA

Clonality: PAb

Anti-MIF Antibody


Application: ELISA

Clonality: PAb

Anti-MIF Antibody


Application: WB,ELISA,IP

Clonality: PAb

Mouse MIF Immunoprecipitation(IP) 8218

Anti-MIF Antibody


Application: WB

Clonality: PAb

Human MIF Western blot (WB) 6596

MIF cDNA Clone (24)


MIF qPCR Primer (2)

MIF IP Kit (1)

MIF Lysate (2)

Macrophage migration inhibitory factor (MIF) is an immunoregulatory cytokine, the effect of which on arresting random immune cell movement was recognized several decades ago. Despite its historic name, MIF also has a direct chemokine-like function and promotes cell recruitment. MIF is an ubiquitously expressed protein that plays a crucial role in many inflammatory and autoimmune disorders. Increasing evidence suggests that MIF also controls metabolic and inflammatory processes underlying the development of metabolic pathologies associated with obesity. Further research has shown that MIF plays a particularly critical part in cell cycle regulation and therefore in tumorigenesis as well. The significance of the role of MIF in a variety of both solid and hematologic tumors has been established. More recently, interest has increased in the role of MIF in the development of central nervous system (CNS) tumors, in which it appears to influence cell cycle control. MIF contributes to malignant disease progression on several different levels. Both circulating and intracellular MIF protein levels are elevated in cancer patients and MIF expression reportedly correlates with stage, metastatic spread and disease-free survival. Blockade of MIF bioactivity successfully inhibited tumor cell growth in vivo and in vitro. MIF plays important roles in the pathogenesis of gastrointestinal, hepatic, and pancreatic disorders.